Literature DB >> 6972306

Histocompatibility requirements for T cell help in specific in vitro antibody responses to influenza virus by human blood lymphocytes.

R E Callard, C M Smith.   

Abstract

Specific antibody responses to influenza virus were obtained in vitro from human blood mononuclear cells (PBM). The response was T cell-dependent, as shown by separation of PBM into E rosette-positive (E+) and -negative (E-) populations. The histocompatibility requirements for T-B cells interactions in this response were analyzed by recombining E- and E+ fractions from donors with varying degrees of HLA compatibility. No antibody formation was obtained from any allogeneic combination except for the special case of HLA identical siblings. As these experiments included combinations with shared or identical HLA-DR specificities, it was unlikely that genetic restriction alone could account for the failure of T-B cell collaboration. Evidence that suppression was responsible for the lack of antibody formation was obtained from experiments in which allogeneic E+ cells profoundly depressed specific antibody responses of intact PBM. In contrast, no such suppression was seen in pokeweed mitogen-driven polyclonal Ig synthesis for which there are no major histocompatibility complex requirements for T cell help. The suppressor activity of allogeneic E+ cells was found to be radiation-sensitive. By irradiating E+ cells, it was, therefore, possible to test for T cell help across an HLA barrier without unwanted suppressor effects. Under these conditions, (irradiated) E+ cells were able to collaborate with allogeneic E- cells even with no HLA alleles in common. This was true even when autologous monocytes were depleted from the helper E+ population. Supernatants collected from antigen-driven cultures of allogeneic E- and E+ cells were able to replace helper T cells in the specific antibody response to influenza virus. The apparent lack of genetic restriction in these responses might, therefore, be explained by the production of a nonrestricted helper factor.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6972306     DOI: 10.1002/eji.1830110309

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  18 in total

1.  The effect of leucyl-leucine methyl ester on proliferation and Ig secretion of EBV-transformed human B lymphocytes.

Authors:  M Ohlin; L Danielsson; R Carlsson; C A Borrebaeck
Journal:  Immunology       Date:  1989-04       Impact factor: 7.397

2.  Human immune responses to herpes simplex virus, varicella-zoster and cytomegalovirus in vitro.

Authors:  S A Williamson; N Parish; J D Chambers; R A Knight
Journal:  Immunology       Date:  1986-03       Impact factor: 7.397

3.  Nature of immunological non-responsiveness to hepatitis B vaccine in healthy individuals.

Authors:  S S Chiou; K Yamauchi; T Nakanishi; H Obata
Journal:  Immunology       Date:  1988-07       Impact factor: 7.397

4.  Effect of cytokines on specific in vitro immunization of human peripheral B lymphocytes against T-cell dependent antigens.

Authors:  L Danielsson; S A Möller; C A Borrebaeck
Journal:  Immunology       Date:  1987-05       Impact factor: 7.397

5.  Antigen-induced human T cell help. Precursor frequency, radiation sensitivity, and allogeneic effects.

Authors:  H C Lane; G Whalen; A S Fauci
Journal:  J Clin Invest       Date:  1983-08       Impact factor: 14.808

6.  Induction of a T-cell mediated suppressor activity by soluble products from antigen-specific helper/inducer human T-cell lines.

Authors:  A Fischer; P Beverley; M Feldmann; S Smith
Journal:  Immunology       Date:  1983-01       Impact factor: 7.397

7.  Specific in vitro antibody response to varicella zoster.

Authors:  R L Souhami; J Babbage; R E Callard
Journal:  Clin Exp Immunol       Date:  1981-10       Impact factor: 4.330

8.  In vitro response to influenza immunisation by peripheral blood mononuclear cells from patients with systemic lupus erythematosus and other autoimmune diseases.

Authors:  L Turner-Stokes; G Cambridge; T Corcoran; J S Oxford; M L Snaith
Journal:  Ann Rheum Dis       Date:  1988-07       Impact factor: 19.103

9.  Specific allogeneic help by T lymphocytes from patients with systemic lupus erythematosus.

Authors:  M K Hari Kumar; R A Knight; M L Snaith
Journal:  Clin Exp Immunol       Date:  1984-10       Impact factor: 4.330

10.  Relative sensitivity of human T cell subsets to deoxyadenosine toxicity.

Authors:  R E Callard; T M Ewing; R M Fox
Journal:  Clin Exp Immunol       Date:  1984-10       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.